Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Sangamo Therapeutics (0R1D.LSE) Q3 2024 Earnings
0R1D.LSE
6
Aug
Confirmed
Q2 2024
Q3 2024
-0.27
-0.23
-0.19
-0.15
Details
Expected EPS
-0.146729
Actual EPS
-0.18
Surprise EPS
-0.03
Surprise Percent
+22.68%
Description
Sangamo Therapeutics (0R1D.LSE) has reported earnings of -0.18 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login